Allspring Global Investments’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
SFM
SBH
N
RA
Allspring Global Investments's ANGO Position: Q4 2024 in Review
Allspring Global Investments sold out of AngioDynamics (ANGO) in Q4 2024, closing a stake of 6,349 shares — an estimated $49.4K sold.
Allspring Global Investments first reported a position in ANGO in Q4 2021 and held it in 12 quarters. The position peaked at $12.1M in Q4 2021. 135 funds tracked by Wall St. Rank hold ANGO as of Q4 2024.
- Allspring Global Investments reported no remaining AngioDynamics position as of Q4 2024 after selling out during the quarter.
- Allspring Global Investments sold 6,349 AngioDynamics shares in Q4 2024, an estimated $49.4K.
- Allspring Global Investments first reported a position in AngioDynamics in Q4 2021 and held it in 12 quarters.
- Allspring Global Investments's AngioDynamics position peaked at $12.1M in Q4 2021.
- 135 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2024.
Based on Allspring Global Investments's 13F filing for Q4 2024, filed 29 Jan 2025.